MedTrace Logo

A Study of People With Multiple Myeloma (MM) in Portugal (CharisMMa-Portugal)

NCT04135963 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2023-10-23

No results posted yet for this study

Summary

The main aim of this study is to see how people with MM respond to previous or current treatment.

Participants will be treated according to their clinic's standard practice. Each participant will fill out a study questionnaire during a routine doctor visit. Information collected from past medical records will also be used.

Conditions

  • Relapse and/or Refractory Multiple Myeloma

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-31
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04135963 on ClinicalTrials.gov